Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections
Page 1 of 1
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections
Jon Moulton Wed Feb 06, 2013 2:05 pm
Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, Ko DC, Zou Y, Bang ND, Chau TT, Vary JC, Hawn TR, Dunstan SJ, Farrar JJ, Thwaites GE, King MC, Serhan CN, Ramakrishnan L. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 2012 Feb 3;148(3):434-46. doi: 10.1016/j.cell.2011.12.023.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Advanced antisense therapies for postexposure protection against lethal filovirus infections
» Interception of host angiogenic signalling limits mycobacterial growth
» An Enzyme That Inactivates the Inflammatory Mediator Leukotriene B4 Restricts Mycobacterial Infection
» TNFα Impairs Rhabdoviral Clearance by Inhibiting the Host Autophagic Antiviral Response
» Carcinoma cells misuse the host tissue damage response to invade the brain
» Interception of host angiogenic signalling limits mycobacterial growth
» An Enzyme That Inactivates the Inflammatory Mediator Leukotriene B4 Restricts Mycobacterial Infection
» TNFα Impairs Rhabdoviral Clearance by Inhibiting the Host Autophagic Antiviral Response
» Carcinoma cells misuse the host tissue damage response to invade the brain
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum